A strategy for managing flu-like symptoms after botulinum toxin injections

J Neurol. 2018 Aug;265(8):1932-1933. doi: 10.1007/s00415-018-8934-4. Epub 2018 Jun 20.

Authors

Edwin B George¹, Adam C Cotton², N Shneyder^{3

4}, H A Jinnah²

Affiliations

¹ Department of Neurology, Wayne State University, University Health Center 8D, 4201 St. Antoine, Detroit, MI, 48201, USA. egeorge@med.wayne.edu.
² Department of Neurology and Human Genetics, Emory University, Atlanta, GA, USA.
³ Department of Neurology, Wayne State University, University Health Center 8D, 4201 St. Antoine, Detroit, MI, 48201, USA.
⁴ Department of Neurology, University of Florida, Jacksonville, FL, USA.

PMID: 29926222
DOI: 10.1007/s00415-018-8934-4

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Botulinum Toxins, Type A / administration & dosage
Botulinum Toxins, Type A / adverse effects*
Disease Management
Drug Substitution
Female
Humans
Injections / adverse effects
Male
Middle Aged
Neuromuscular Agents / administration & dosage
Neuromuscular Agents / adverse effects*
Young Adult

Substances

Neuromuscular Agents
Botulinum Toxins, Type A
incobotulinumtoxinA

Grants and funding